Skip to content
HowShorted

PMV Pharmaceuticals, Inc. short interest in 2025

In 2025, PMV Pharmaceuticals, Inc.'s disclosed short interest ran from 2.66% of shares outstanding on 15 Jan 2025 to 3.03% on 31 Dec 2025, a change of +0.37 percentage points. The year's high was 3.03% on 31 Dec 2025 and its low 1.42% on 30 Sep 2025, averaging 1.96% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.29 days on 14 Feb 2025. Full history: PMV Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PMV Pharmaceuticals, Inc. in 2025

2025 in figures

Start of year
2.66% (15 Jan 2025)
End of year
3.03% (31 Dec 2025)
Change
+0.37 pp
High
3.03% (31 Dec 2025)
Low
1.42% (30 Sep 2025)
Average
1.96%
Highest days to cover
10.29 (14 Feb 2025)
SEC filings marked
8

Every report in 2025

PMV Pharmaceuticals, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20252.66%7.59
31 Jan 20251.66%5.80
14 Feb 20251.67%10.29
28 Feb 20251.69%6.18
14 Mar 20251.71%6.7310-K filed, results (8-K)
31 Mar 20251.61%9.62
15 Apr 20251.61%5.36
30 Apr 20251.65%9.58
15 May 20251.62%3.4710-Q filed, results (8-K)
30 May 20251.64%2.49
13 Jun 20251.67%2.25
30 Jun 20251.81%7.31
15 Jul 20251.48%2.13
31 Jul 20251.58%2.57
15 Aug 20251.52%3.8610-Q filed, results (8-K)
29 Aug 20251.53%1.65
15 Sep 20251.44%1.00
30 Sep 20251.42%1.00
15 Oct 20252.88%2.62
31 Oct 20252.87%1.88
14 Nov 20252.88%5.9010-Q filed, results (8-K)
28 Nov 20252.53%5.73
15 Dec 20252.96%5.13
31 Dec 20253.03%7.14

See also: PMV Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.